Welcome to Primary Care Pages (PCP), a dedicated portal for General Practitioners. Please register an account with us to access our one-stop resource hub.
Thank you for visiting the Primary Care Pages. Please proceed to log in with your Member ID and password.
Primary Care Pages is enabled with 2FA.
Click here to set up.
Overview of primary care sector
Overview of how AIC can support you in primary care
Find out how these schemes can support your practice
Stay up to date on issues impacting your practice
A one-stop resource for IT solutions
Find out how these models can support your practice
Check out opportunities for further training and collaboration
Quick links to access useful healthcare portals
A one-stop resource page on COVID-19
Clinical guidelines and resources for holistic care
Managing pandemic situations in general practice
Materials to supplement patient engagement
Important information impacting your practice
Stay tune with latest primary care updates
Useful primary care articles catered for you
Checkout the latest buzz on primary care deals here
A consolidation of events and trainings organised just for you
For enquiry, feedback and compliment
For IDAPE accessor to update particulars
Onsite training for related Primary Care schemes/models
For IDAPE accessor to withdraw from IDAPE
To list your clinic in Singapore Silver Pages
Search for medical support and services
Only selected vaccine brands listed on the SVL will be eligible for NAIS and NCIS vaccination subsidies. MOH may review the listings periodically, in response to new price proposals from manufacturers, regulatory approval of new vaccines and other changes in global market conditions. Only selected vaccine brands listed on the SVL will be eligible for vaccination subsidies.
CHAS GPs can use the vaccines purchased at prices no higher than Special Pricing Arrangements for the public, including non-subsidised population and non-citizens, with the exception of the following vaccine brands marketed by GSK and Pfizer. The Special Pricing Arrangements for the vaccine brands below marketed by GSK and Pfizer shall apply only to patients who are eligible for subsidies.
• Boostrix • Cervarix • Engerix-B • Fluarix Tetra • Infanrix-IPV + Hib • Infanrix Hexa • Priorix • Priorix-Tetra • Synflorix • Varilrix • Prevenar 13
Under the Special Pricing Arrangements, the vaccine manufacturers are obliged to sell at no higher than Special Pricing Arrangements to all CHAS GPs from 1 Oct 2020 as part of this vaccine subsidy program. Please be reminded that for the vaccine brands listed above, the vaccines purchased under the Special Pricing Arrangements should only be used for subsidised patients, from 1 Nov 2020 onwards.
CHAS GP clinics are advised to discuss procurement arrangements early with these vaccine manufacturers, including differentiation of stocks, availability of stocks and flexibility to use private stocks for subsidised patients.
Measures will be put in place to monitor the appropriate use of vaccines obtained under the Special Pricing Arrangements; penalties may be imposed on errant GPs who administer the above-listed vaccines to non-subsidised patients or who resell the vaccines.
Special Pricing Arrangements:MOH has negotiated with vaccine manufacturers so that CHAS GP clinics can obtain nationally recommended vaccines listed on the Subsidised Vaccine List (SVL) at favourable prices. Legally-binding special pricing arrangements (SPAs) are in place to require the manufacturers to sell the vaccines listed in the SVL to CHAS GP clinics at no higher than MOH-negotiated procurement price caps (PPCs) from 1 Oct 2020.
Name : Marie TiersPosition: Vaccine Business ExecutiveEmail : email@example.com Mobile : +65 8693 4500
Charmaine Chock (firstname.lastname@example.org) Sashi Varman (email@example.com)
This is only meant for the purchase of SPA vaccines under vaccination subsidy scheme at CHAS GP clinics.